School of Materials Science and Engineering, South China University of Technology, Guangzhou 510006, P. R. China.
Biomater Sci. 2018 Dec 18;7(1):51-62. doi: 10.1039/c8bm01054d.
The cornea repair materials amniotic membrane, acellular corneal stroma, and natural polymer-based materials have excellent biocompatibility and support epithelization. However, few researchers have focused on corneal stromal wound healing repair with regard to scar formation and transparency improvements. Herein, we introduced nanocomplexes of gold nanoparticles (AuNPs) and microRNA-133b (miR-133b) into collagen-based material to achieve corneal repair and scar inhibition. We evaluated the cytocompatibility of AuNPs and the ability of miRNA-133b to inhibit myofibroblast transformation in vitro. The AuNPs had no cytotoxicity at working concentrations, and AuNP/miR-133b complexes down-regulated the expression of myofibroblast transformation genes (alpha-smooth muscle actin and type I collagen) in corneal stromal cells. We then loaded AuNP/miR-133b complexes into collagen using two methods: loading on the surface (Col-AMS) and loading inside (Col-AMI) the collagen membrane. The results showed that AuNP/miR-133b introduction did not affect water content, light transmittance, or the mechanical properties of the collagen membrane. MiR-133b can maintain its integrity during the preparation of materials. In vivo lamellar keratoplasty results showed that the cornea epithelized completely and rapidly. Corneas without transplantation and with the transplantation of a non-modified collagen membrane became cloudy after trauma to different degrees after approximately 14 days. Interestingly, cornea transparency was retained after transplantation with Col-AMS and Col-AMI. Hematoxylin-eosin-stained histologic sections revealed that the corneas transplanted with Col-AMS and Col-AMI were similar to healthy corneas. Immunohistochemical staining revealed lower a-SM and Col-1 expression in corneal stroma after transplantation with collagen combined with AuNP/miR-133b. Our results thus suggest that collagen membranes combined with AuNP/miR-133b complexes can rapidly repair corneas and effectively inhibit scar formation.
角膜修复材料如羊膜、脱细胞角膜基质和天然聚合物材料具有极好的生物相容性,并能支持上皮化。然而,很少有研究关注角膜基质伤口愈合修复与瘢痕形成和透明度改善。在此,我们将金纳米粒子(AuNPs)和 microRNA-133b(miR-133b)纳米复合物引入到胶原基材料中,以实现角膜修复和抑制瘢痕。我们评估了 AuNPs 的细胞相容性和 miR-133b 抑制角膜基质细胞成纤维细胞转分化的能力。AuNPs 在工作浓度下无细胞毒性,AuNP/miR-133b 复合物下调了角膜基质细胞中成纤维细胞转分化基因(α-平滑肌肌动蛋白和 I 型胶原)的表达。然后,我们使用两种方法将 AuNP/miR-133b 复合物载入胶原:载入胶原膜表面(Col-AMS)和载入胶原膜内部(Col-AMI)。结果表明,AuNP/miR-133b 的引入不影响胶原膜的含水量、透光率或机械性能。miR-133b 在材料制备过程中保持完整。体内板层角膜移植结果表明,角膜完全快速上皮化。未经移植和移植非修饰胶原膜的角膜在创伤后约 14 天后不同程度地变得混浊。有趣的是,移植 Col-AMS 和 Col-AMI 后角膜保持透明。苏木精-伊红染色的组织切片显示,移植 Col-AMS 和 Col-AMI 的角膜与健康角膜相似。免疫组织化学染色显示,移植胶原结合 AuNP/miR-133b 后角膜基质中 a-SM 和 Col-1 的表达降低。因此,我们的研究结果表明,胶原膜结合 AuNP/miR-133b 复合物可以快速修复角膜,并有效抑制瘢痕形成。